XML 53 R37.htm IDEA: XBRL DOCUMENT v3.25.3
Subsequent Events (Details)
$ / shares in Units, $ in Millions
1 Months Ended
Dec. 05, 2025
USD ($)
Nov. 21, 2025
USD ($)
Nov. 07, 2025
USD ($)
milestone
$ / shares
Oct. 28, 2025
USD ($)
Oct. 24, 2025
USD ($)
Oct. 31, 2025
USD ($)
Subsequent Event            
Subsequent Event [Line Items]            
Common stock, par or stated value (in USD per share) | $ / shares     $ 0.0001      
Subsequent Event | Lilly, and Flying Tigers Acquisition Corporation Merger | Forecast            
Subsequent Event [Line Items]            
Common stock, exchange price (in USD per share) | $ / shares     3.56      
Contingent value rights, per share (in USD per share) | $ / shares     $ 8.91      
Milestones to be achieved | milestone     2      
Termination fees     $ 4.0      
North Carolina Lease Settlement Agreement, Cash Settlement | Subsequent Event            
Subsequent Event [Line Items]            
Proceeds from legal settlements           $ 9.5
Secured Promissory Note | Secured Debt | Forecast            
Subsequent Event [Line Items]            
Funding from secured debt financing $ 25.0 $ 20.0        
Secured Promissory Note | Secured Debt | Subsequent Event            
Subsequent Event [Line Items]            
Secured debt financing         $ 65.0  
Funding from secured debt financing     $ 15.0 $ 5.0    
Debt instrument, basis spread (percent)         10.00%  
Debt instrument, prepayment premium (percent)         0.050  
Upon U.S. approval of Ixo-vec prior to seventh anniversary | Subsequent Event | Lilly, and Flying Tigers Acquisition Corporation Merger | Forecast            
Subsequent Event [Line Items]            
Contingent value rights, per share (in USD per share) | $ / shares     $ 1.78      
Upon first achievement of annual worldwide net sales of Ixo-vec | Subsequent Event | Lilly, and Flying Tigers Acquisition Corporation Merger | Forecast            
Subsequent Event [Line Items]            
Contingent value rights, per share (in USD per share) | $ / shares     $ 7.13      
Licensees exceeding amount     $ 1,000.0